Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus.
The lateral hypothalamus (LH) is a central hub that integrates inputs from, and sends outputs to, many other brain areas. Two groups of neurons in the LH, expressing hypocretin/orexin or melanin concentrating hormone (MCH), have been shown to participate in sleep regulation, energy homeostasis, drug addiction, motor regulation, stress response, and social behaviors. The elucidation of crosstalk between these two systems is essential to understand these behaviors and functions because there is evidence that there are reciprocal innervations between hypocretin/orexin and MCH neurons. In this study, we used MCH receptor-1 knock-out (MCHR1 KO) and wild-type (WT) mice expressing green fluorescent protein in hypocretin/orexin-containing neurons to examine the hypothesis that MCH modulates hypocretin/orexin-mediated effects on behavioral state and synaptic transmission in the LH. In MCHR1 KO mice, the efficacy of glutamatergic synapses on hypocretin/orexin neurons is potentiated and hypocretin-1-induced action potential firing is facilitated, potentially explaining an increased effect of modafinil observed in MCHR1 KO mice. In wild-type mice with intact MCHR1 signaling, MCH significantly attenuated the hypocretin-1-induced enhancement of spike frequency in hypocretin/orexin neurons. The MCH effect was dose dependent, pertussis toxin sensitive, and was abolished in MCHR1 KO mice. Consistent with this effect, MCH attenuated hypocretin-1-induced enhancement of the frequency of miniature EPSCs in hypocretin/orexin neurons. These data from MCHR1 KO and WT mice demonstrate a novel interaction between these two systems, implying that MCH may exert a unique inhibitory influence on hypocretin/orexin signaling as a way to fine-tune the output of the LH.
Rao
Yan
Y
Department of Obstetrics/Gynecology and Reproductive Science, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Lu
Min
M
Ge
Fei
F
Marsh
Donald J
DJ
Qian
Su
S
Wang
Alex Hanxiang
AH
Picciotto
Marina R
MR
Gao
Xiao-Bing
XB
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal; D001552:Benzazepines / Q000494:pharmacology; D001559:Benzhydryl Compounds / Q000494:pharmacology; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D018491:Dopamine Agonists / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D018683:Excitatory Amino Acid Agents / Q000494:pharmacology; D018698:Glutamic Acid / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D007026:Hypothalamic Area, Lateral / Q000166:cytology*; D007028:Hypothalamic Hormones / Q000378:metabolism* / Q000494:pharmacology; D066298:In Vitro Techniques; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D008543:Melanins / Q000378:metabolism* / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D000077408:Modafinil; D009043:Motor Activity / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009479:Neuropeptides / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D000068797:Orexins; D037342:Pertussis Toxin / Q000494:pharmacology; D010907:Pituitary Hormones / Q000378:metabolism* / Q000494:pharmacology; D017481:Receptors, Somatostatin / Q000172:deficiency; D013569:Synapses / Q000187:drug effects / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D013997:Time Factors
D001552:Benzazepines; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D018491:Dopamine Agonists; D018683:Excitatory Amino Acid Agents; D007028:Hypothalamic Hormones; D047908:Intracellular Signaling Peptides and Proteins; C491209:Mchr1 protein, mouse; D008543:Melanins; D009479:Neuropeptides; D000068797:Orexins; D010907:Pituitary Hormones; D017481:Receptors, Somatostatin; D049452:Green Fluorescent Proteins; D018698:Glutamic Acid; C019463:melanin-concentrating hormone; C067113:SK&F 81297; D037342:Pertussis Toxin; D000077408:Modafinil
J Comp Neurol. 2003 Oct 27;465(4):593-603
12975818
Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R382-7
16902182
Curr Opin Clin Nutr Metab Care. 2003 Jul;6(4):353-60
12806206
J Neurosci. 2003 Mar 1;23(5):1557-62
12629156
J Neurosci. 2005 Jan 26;25(4):914-22
15673672
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7
9419374
Regul Pept. 2007 Mar 1;139(1-3):23-30
17045349
Lancet. 2000 Jan 1;355(9197):39-40
10615891
Nature. 1996 Mar 21;380(6571):243-7
8637571
J Neurophysiol. 2006 Jul;96(1):284-98
16611835
Endocrinology. 2000 Dec;141(12):4524-32
11108264
Nature. 2005 Sep 22;437(7058):556-9
16100511
Biochem Biophys Res Commun. 1998 Dec 18;253(2):241-5
9878522
J Clin Invest. 2007 Dec;117(12):4022-33
18060037
J Neurosci. 2004 Aug 11;24(32):7159-66
15306649
J Neurosci Res. 2000 Oct 15;62(2):161-8
11020209
Int J Obes Relat Metab Disord. 2002 Dec;26(12):1523-32
12461668
J Comp Neurol. 2007 Nov 10;505(2):147-57
17853446
Endocrinology. 2003 Aug;144(8):3514-23
12865333
Mol Neurobiol. 2005 Dec;32(3):285-94
16385142
Neuron. 2002 Dec 19;36(6):1169-81
12495630
Neuropsychopharmacology. 2006 Jun;31(6):1135-45
16205780
Cell. 1999 Aug 6;98(3):365-76
10458611
J Neurosci. 2006 Jan 11;26(2):398-405
16407535
Synapse. 2008 Feb;62(2):128-36
18000809
J Neurosci. 1998 Oct 1;18(19):7962-71
9742163
J Neurosci. 2006 Sep 27;26(39):10043-50
17005867
Nature. 1999 Jul 15;400(6741):261-5
10421367
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10085-90
12897241
Eur J Neurosci. 2005 May;21(10):2807-16
15926928
Neuroscience. 2005;130(4):807-11
15652980
Regul Pept. 2005 Jan 15;124(1-3):53-63
15544841
Nat Cell Biol. 1999 Sep;1(5):267-71
10559938
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3240-5
11867747
J Physiol. 2001 May 15;533(Pt 1):237-52
11351031
J Neurosci. 2004 Mar 24;24(12):3013-22
15044540
Regul Pept. 2003 Jul 15;114(2-3):79-86
12832094
Cell. 1998 Feb 20;92(4):573-85
9491897
J Physiol. 2006 Jul 15;574(Pt 2):399-414
16627567
Psychopharmacology (Berl). 1994 May;114(4):597-600
7855221
Cell Metab. 2005 Apr;1(4):279-86
16054072
J Neurosci. 2000 Nov 15;20(22):8620-8
11069971
Cell. 1999 Aug 20;98(4):437-51
10481909
Peptides. 2004 Oct;25(10):1605-11
15476927
Eur J Pharmacol. 2008 Jan 28;579(1-3):177-88
18062961
Diabetes. 1999 Nov;48(11):2132-7
10535445
BMC Neurosci. 2003 Sep 09;4:19
12964948
Neuron. 2003 Jun 5;38(5):701-13
12797956
J Comp Neurol. 1998 Dec 28;402(4):435-41
9862319
J Neurophysiol. 2007 Jan;97(1):837-48
17093123
J Exp Zool A Comp Exp Biol. 2006 Sep 1;305(9):761-8
16902961
J Neurosci. 1998 Dec 1;18(23):9996-10015
9822755
J Physiol. 2002 Jul 1;542(Pt 1):273-86
12096069
Neuron. 2006 Feb 16;49(4):589-601
16476667
Prog Brain Res. 2006;153:243-52
16876579
J Neurosci. 2005 Mar 16;25(11):2933-40
15772353
Auton Neurosci. 2006 Jun 30;126-127:139-45
16574499
J Comp Neurol. 1992 May 8;319(2):218-45
1522246
Brain Res. 2000 Aug 4;873(1):181-7
10915829
Neuron. 2004 May 27;42(4):635-52
15157424
J Neurosci. 2005 Aug 10;25(32):7459-69
16093397
Nature. 1999 Jul 15;400(6741):265-9
10421368
FEBS Lett. 1999 Sep 3;457(3):522-4
10471841